Treatment-resistant depression: therapeutic trends, challenges, and future directions
Khalid Saad Al-HarbiMedical College, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi ArabiaBackground: Patients with major depression respond to antidepressant treatment, but 10%–30% of them do not improve or show a partial...
Main Author: | Al-Harbi KS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-05-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/treatment-resistant-depression-therapeutic-trends-challenges-and-futur-a9799 |
Similar Items
-
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
by: Ostendorf AP, et al.
Published: (2017-04-01) -
Neuromodulation therapies and treatment-resistant depression
by: Al-Harbi KS, et al.
Published: (2012-07-01) -
Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions
by: Yu Tang, et al.
Published: (2021-03-01) -
Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder
by: Kaur M, et al.
Published: (2021-02-01) -
Management of Treatment-Resistant Depression: Challenges and Strategies
by: Voineskos D, et al.
Published: (2020-01-01)